Skip to main content
Premium Trial:

Request an Annual Quote

Oncomethylome Sciences Gets ISO Certification

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oncomethylome Sciences today said that its Belgium-based clinical diagnostics services lab has received ISO 9001:2008 certification.

The certification, which was provided by Lloyds Register Quality Assurance, confirms that the lab's quality management system "consistently meets customer and regulatory requirements for research, design, assay development, and clinical molecular diagnostic service testing," said Oncomethylome in a statement.

The Liege, Belgium-based firm makes tests based on gene methylation technology that are intended to help physicians detect the early stages of cancer development, predict response to therapy, and predict the likelihood of cancer recurrence.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.